|
Quotes & Info
|
| FOLD > SEC Filings for FOLD > Form 8-K on 22-Feb-2013 | All Recent SEC Filings |
22-Feb-2013
Change in Directors or Principal Officers
(b) On February 22, 2013, Amicus Therapeutics, Inc. (the "Company") and Pol F. Boudes, M.D., Chief Medical Officer of the Company, mutually agreed that Dr. Boudes would leave the Company to pursue other opportunities effective as of April 30, 2013.
|
|